Okay, let's tackle this question about metyrapone. The question is asking how metyrapone acts. First, I need to remember what metyrapone does. I recall that it's related to the adrenal gland and cortisol production. Metyrapone is an inhibitor of 11β-hydroxylase, which is an enzyme in the cortisol synthesis pathway. So, by inhibiting this enzyme, metyrapone blocks the conversion of 11-deoxycortisol to cortisol.

Now, the options aren't given, but common distractors in such questions might include other enzymes or mechanisms. For example, someone might confuse it with ketoconazole, which inhibits multiple enzymes in the steroid pathway, or maybe aminoglutethimide, which inhibits cholesterol desmolase. Another possible wrong option could be something like inhibiting the pituitary gland, but metyrapone's action is more direct on the adrenal cortex.

The core concept here is the inhibition of 11β-hydroxylase in the adrenal cortex. The correct answer would be that metyrapone blocks the conversion of 11-deoxycortisol to cortisol. The other options would involve different enzymes or mechanisms. For instance, if an option says it inhibits 21-hydroxylase, that's incorrect because that's a different step in the pathway. Similarly, if an option mentions ACTH suppression, that's a result of the feedback mechanism, not the direct action of metyrapone.

The clinical pearl here is that metyrapone is used in the diagnosis of Cushing's syndrome by the metyrapone test, which measures the ability of the adrenal glands to synthesize cortisol. High 11-deoxycortisol levels after administration indicate a problem in the adrenal cortex, while normal levels suggest a pituitary or hypothalamic issue.

So, putting it all together, the correct answer is the inhibition of 11β-hydroxylase, leading to decreased cortisol production. The wrong options would be other enzymes or mechanisms not directly related to this pathway.

**Core Concept**
Metyrapone is a synthetic steroid that inhibits **11β-hydroxylase**, an enzyme in the adrenal cortex responsible for converting **11-deoxycortisol to cortisol**. This action is critical in diagnosing and managing **Cushing’s syndrome**.

**Why the Correct Answer is Right**
By blocking 11β-hydroxylase, metyrapone prevents the final step of cortisol synthesis. This leads to elevated **11-deoxycortisol** levels and reduced cortisol, stimulating **ACTH release** via negative feedback. The resulting increase in **tetrahydrocortisone** and **tetrahydrocortisol** (metabolites) in urine confirms adrenal cortex function in the metyrapone test.

**Why Each Wrong Option is Incorrect**
**Option A:** Inhibits 21-hydroxylase – Incorrect. 21-hydroxylase deficiency causes congenital adrenal hyperplasia, unrelated to metyrapone’s mechanism.
**Option B:** Blocks ACTH secretion – Incorrect. Metyrapone indirectly increases ACTH due to cortisol depletion, but it does not directly inhibit the pituitary.
**

✓ Correct Answer: C. Inhibition of 11b-Hydroxylase